Back to Explorer

CPG Sec. 150.200 Compliance Review of Private Laboratory Analytical Packages (PLAPs)

FinalOffice of Inspections and Investigations09/01/2016

Description

The purpose of this document is to provide guidance for FDA staff when receiving and reviewing private laboratory analytical packages (PLAPs). Importers typically submit PLAPs to FDA to provide information regarding the admissibility of articles that are held under detention without physical examination (DWPE) due to the appearance of a violation. The policy described in this document applies to: 1) FDA compliance personnel review of the non-technical aspects of a PLAP; and 2) FDA compliance personnel determination of admissibility after the technical review of a PLAP is completed by an ORA Field Laboratory.

Scope & Applicability

Stakeholders

2
third-party laboratories

Entities that often prepare Private Laboratory Analytical Packages.

importer

Person responsible for establishing FSVP; Person in the United States who owns or has purchased the food at time of entry; entity responsible for FSVP compliance; Entity responsible for FSVP compliance; Entity responsible for conducting hazard analysis; Subject of FSVP requirements for food for humans and animals.; The entity responsible for FSVP compliance and supplier approval.; entity responsible for foreign supplier verification; entity responsible for developing FSVP; entity responsible for

Regulatory Context

Attributes

1
sample integrity

A factor assessed during the non-technical review of a PLAP.

Related CFR Sections (1)

See Also (3)

CPG Sec. 150.200 Compliance Review of Private Laboratory Analytical Packages (PLAPs) | Guideline Explorer | BioRegHub